Dezhan Healthcare Co

Dezhan Healthcare Co EBITDA per Share

The EBITDA per Share of Dezhan Healthcare Co (000813.SZ) as of Nov 5, 2026 is -0.08 CNY.

EBITDA per Share

-0.08CNY

YoY

-2,765.69%

Last updated:

EBITDA per Share of Dezhan Healthcare Co is 2025 -0.08 CNY. EBITDA per Share of Dezhan Healthcare Co was 2024 0.00 CNY. It decreases by -2,765.69% lower compared to the previous year.

The Dezhan Healthcare Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.48 CNY
Jan 1, 2019
0.18 CNY
Jan 1, 2020
0.17 CNY
Jan 1, 2021
0.00 CNY
Jan 1, 2022
-0.03 CNY
Jan 1, 2023
0.06 CNY
Jan 1, 2024
0.00 CNY
Jan 1, 2025
-0.08 CNY
The Dezhan Healthcare Co EBITDA per Share history
YEAREBITDA per ShareYoY
-0.08CNY-2,765.69%
0.00CNY-94.76%
0.06CNY-277.81%
-0.03CNY-2,590.69%
0.00CNY-99.23%
0.17CNY-3.03%
0.18CNY-62.94%
0.48CNY+12.49%
0.43CNY-28.66%
0.60CNY-32.46%
0.88CNY+42.73%
0.62CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dezhan Healthcare Co Stock analysis

What does Dezhan Healthcare Co do? Dezhan Healthcare Co., Ltd. generates revenue through the development and sale of cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. The company's subsidiaries produce injections, biopharmaceuticals, and Chinese medicine preparations to optimize product structures and meet diverse market demands. Its primary market is China, where it targets consumers seeking health and wellness solutions through pharmaceutical and functional beverage offerings. The firm focuses on human life sciences research, emphasizing cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. Subsidiaries introduce production lines for multiple dosage forms, including injections, biopharmaceuticals, and Chinese medicine preparations, to enhance product variety and meet specific consumer needs within the Chinese market. Sales are driven by the domestic demand for health-focused pharmaceutical and beverage products. Dezhan Healthcare Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dezhan Healthcare Co stock

EBITDA per Share of Dezhan Healthcare Co is -0.08 CNY in 2025.

On Eulerpool you can find the complete historical development of EBITDA per Share Dezhan Healthcare Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Dezhan Healthcare Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Dezhan Healthcare Co